miR-1323 suppresses bone mesenchymal stromal cell osteogenesis and fracture healing via inhibiting BMP4/SMAD4 signaling

Abstract Background Atrophic non-union fractures show no radiological evidence of callus formation within 3 months of fracture. microRNA dysregulation may underlie the dysfunctional osteogenesis in atrophic non-union fractures. Here, we aimed to analyze miR-1323 expression in human atrophic non-unio...

Full description

Bibliographic Details
Main Authors: Hui Xie, Ming Liu, Yaofeng Jin, Haiqing Lin, Yushan Zhang, Song Zheng
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13018-020-01685-8
_version_ 1811298070451716096
author Hui Xie
Ming Liu
Yaofeng Jin
Haiqing Lin
Yushan Zhang
Song Zheng
author_facet Hui Xie
Ming Liu
Yaofeng Jin
Haiqing Lin
Yushan Zhang
Song Zheng
author_sort Hui Xie
collection DOAJ
description Abstract Background Atrophic non-union fractures show no radiological evidence of callus formation within 3 months of fracture. microRNA dysregulation may underlie the dysfunctional osteogenesis in atrophic non-union fractures. Here, we aimed to analyze miR-1323 expression in human atrophic non-union fractures and examine miR-1323’s underlying mechanism of action in human mesenchymal stromal cells. Methods Human atrophic non-union and standard healing fracture specimens were examined using H&E and Alcian Blue staining, immunohistochemistry, qRT-PCR, immunoblotting, and ALP activity assays. The effects of miR-1323 mimics or inhibition on BMP4, SMAD4, osteogenesis-related proteins, ALP activity, and bone mineralization were analyzed in human mesenchymal stromal cells. Luciferase reporter assays were utilized to assay miR-1323’s binding to the 3'UTRs of BMP4 and SMAD4. The effects of miR-1323, BMP4, and SMAD4 were analyzed by siRNA and overexpression vectors. A rat femur fracture model was established to analyze the in vivo effects of antagomiR-1323 treatment. Results miR-1323 was upregulated in human atrophic non-union fractures. Atrophic non-union was associated with downregulation of BMP4 and SMAD4 as well as the osteogenic markers ALP, collagen I, and RUNX2. In vitro, miR-1323 suppressed BMP4 and SMAD4 expression by binding to the 3'UTRs of BMP4 and SMAD4. Moreover, miR-1323’s inhibition of BMP4 and SMAD4 inhibited mesenchymal stromal cell osteogenic differentiation via modulating the nuclear translocation of the transcriptional co-activator TAZ. In vivo, antagomiR-1323 therapy facilitated the healing of fractures in a rat model of femoral fracture. Conclusions This evidence supports the miR-1323/BMP4 and miR-1323/SMAD4 axes as novel therapeutic targets for atrophic non-union fractures.
first_indexed 2024-04-13T06:14:20Z
format Article
id doaj.art-43a4fc5717cd4b77a48681c7bcda1389
institution Directory Open Access Journal
issn 1749-799X
language English
last_indexed 2024-04-13T06:14:20Z
publishDate 2020-06-01
publisher BMC
record_format Article
series Journal of Orthopaedic Surgery and Research
spelling doaj.art-43a4fc5717cd4b77a48681c7bcda13892022-12-22T02:58:54ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2020-06-0115111310.1186/s13018-020-01685-8miR-1323 suppresses bone mesenchymal stromal cell osteogenesis and fracture healing via inhibiting BMP4/SMAD4 signalingHui Xie0Ming Liu1Yaofeng Jin2Haiqing Lin3Yushan Zhang4Song Zheng5Department of Orthopedics, The Second Affiliated Hospital of Jiaxing UniversityDepartment of Orthopedics, The Second Affiliated Hospital of Jiaxing UniversityDepartment of Orthopedics, The Second Affiliated Hospital of Jiaxing UniversityDepartment of Orthopedics, The Second Affiliated Hospital of Jiaxing UniversityDepartment of Orthopedics, The Second Affiliated Hospital of Jiaxing UniversityDepartment of Orthopedics, The Second Affiliated Hospital of Jiaxing UniversityAbstract Background Atrophic non-union fractures show no radiological evidence of callus formation within 3 months of fracture. microRNA dysregulation may underlie the dysfunctional osteogenesis in atrophic non-union fractures. Here, we aimed to analyze miR-1323 expression in human atrophic non-union fractures and examine miR-1323’s underlying mechanism of action in human mesenchymal stromal cells. Methods Human atrophic non-union and standard healing fracture specimens were examined using H&E and Alcian Blue staining, immunohistochemistry, qRT-PCR, immunoblotting, and ALP activity assays. The effects of miR-1323 mimics or inhibition on BMP4, SMAD4, osteogenesis-related proteins, ALP activity, and bone mineralization were analyzed in human mesenchymal stromal cells. Luciferase reporter assays were utilized to assay miR-1323’s binding to the 3'UTRs of BMP4 and SMAD4. The effects of miR-1323, BMP4, and SMAD4 were analyzed by siRNA and overexpression vectors. A rat femur fracture model was established to analyze the in vivo effects of antagomiR-1323 treatment. Results miR-1323 was upregulated in human atrophic non-union fractures. Atrophic non-union was associated with downregulation of BMP4 and SMAD4 as well as the osteogenic markers ALP, collagen I, and RUNX2. In vitro, miR-1323 suppressed BMP4 and SMAD4 expression by binding to the 3'UTRs of BMP4 and SMAD4. Moreover, miR-1323’s inhibition of BMP4 and SMAD4 inhibited mesenchymal stromal cell osteogenic differentiation via modulating the nuclear translocation of the transcriptional co-activator TAZ. In vivo, antagomiR-1323 therapy facilitated the healing of fractures in a rat model of femoral fracture. Conclusions This evidence supports the miR-1323/BMP4 and miR-1323/SMAD4 axes as novel therapeutic targets for atrophic non-union fractures.http://link.springer.com/article/10.1186/s13018-020-01685-8FractureAtrophic non-unionBMP4SMAD4miR-1323
spellingShingle Hui Xie
Ming Liu
Yaofeng Jin
Haiqing Lin
Yushan Zhang
Song Zheng
miR-1323 suppresses bone mesenchymal stromal cell osteogenesis and fracture healing via inhibiting BMP4/SMAD4 signaling
Journal of Orthopaedic Surgery and Research
Fracture
Atrophic non-union
BMP4
SMAD4
miR-1323
title miR-1323 suppresses bone mesenchymal stromal cell osteogenesis and fracture healing via inhibiting BMP4/SMAD4 signaling
title_full miR-1323 suppresses bone mesenchymal stromal cell osteogenesis and fracture healing via inhibiting BMP4/SMAD4 signaling
title_fullStr miR-1323 suppresses bone mesenchymal stromal cell osteogenesis and fracture healing via inhibiting BMP4/SMAD4 signaling
title_full_unstemmed miR-1323 suppresses bone mesenchymal stromal cell osteogenesis and fracture healing via inhibiting BMP4/SMAD4 signaling
title_short miR-1323 suppresses bone mesenchymal stromal cell osteogenesis and fracture healing via inhibiting BMP4/SMAD4 signaling
title_sort mir 1323 suppresses bone mesenchymal stromal cell osteogenesis and fracture healing via inhibiting bmp4 smad4 signaling
topic Fracture
Atrophic non-union
BMP4
SMAD4
miR-1323
url http://link.springer.com/article/10.1186/s13018-020-01685-8
work_keys_str_mv AT huixie mir1323suppressesbonemesenchymalstromalcellosteogenesisandfracturehealingviainhibitingbmp4smad4signaling
AT mingliu mir1323suppressesbonemesenchymalstromalcellosteogenesisandfracturehealingviainhibitingbmp4smad4signaling
AT yaofengjin mir1323suppressesbonemesenchymalstromalcellosteogenesisandfracturehealingviainhibitingbmp4smad4signaling
AT haiqinglin mir1323suppressesbonemesenchymalstromalcellosteogenesisandfracturehealingviainhibitingbmp4smad4signaling
AT yushanzhang mir1323suppressesbonemesenchymalstromalcellosteogenesisandfracturehealingviainhibitingbmp4smad4signaling
AT songzheng mir1323suppressesbonemesenchymalstromalcellosteogenesisandfracturehealingviainhibitingbmp4smad4signaling